ACTRN12618000978268终止未知
AusTAPER Pilot: Team Approach to Polypharmacy Evaluation and Reduction A pilot feasibility study for older patients in General Practice
niversity of Newcastle0 个研究点目标入组 24 人开始时间: 2018年6月12日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 终止
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 70 Years 至 o limit（—）
- 性别
- All
入选标准
- •i) aged 70 years or more
- •ii) Taking 5 or more different regular medicines (prescribed medicines/over the counter and complementary and alternative medicines & herbal and mineral supplements)
- •iii) Regular patient at the participating GP practice
- •iv) Living in community
排除标准
- •i) Inadequate language skills to participate
- •ii) Are in terminal phase of life, or not available for 6 month study follow-up
- •iii) Place of residence is a Residential Aged Care Facility (RACF)
- •iv) Diagnosis of Dementia or Alzheimers (as recorded by GP)
- •v) Have had a comprehensive community pharmacist or GP-led medication review within the last 12 months
研究者
相似试验
尚未招募
4 期
The Australian Team Approach to Polypharmacy Evaluation and Reduction (AusTAPER) study for older hospital inpatientsPolypharmacyACTRN12618000979257niversity of Western Australia250
进行中（未招募）
不适用
AusTAPER Dem: Team Approach to Polypharmacy Evaluation and Reductionfor General Practice patients with dementia: the Australian TAPER Dem studydementiaACTRN12619000453189University of Western Australia31
尚未招募
不适用
Team Approach to Polypharmacy Evaluation and Reductionfor General Practice patients: the Australian TAPER (AusTAPER) studyPolypharmacyPublic Health - Health service researchACTRN12620001169932niversity Of Sydney360
进行中（未招募）
1 期
Etude pilote de la pharmacocinétique, de la tolérance et de l’efficacité du raltégravir associé à deux molécules actives parmi les analogues nucléosi(ti)diques et l’enfuvirtide, avant et après transplantation hépatique chez des patients VIH+ en insuffisance hépatique sévère. - LIVERAPériode 1 : Hepatic insufficiency Période 2 Liver transplantation chez les patients infectés par le VIH-1MedDRA version: 12.0Level: LLTClassification code 10056542Term: <Manually entered code. Term in E.1.1>MedDRA version: 12.0Level: LLTClassification code 10024716Term: <Manually entered code. Term in E.1.1>MedDRA version: 12.0Level: LLTClassification code 10020161Term: <Manually entered code. Term in E.1.1>EUCTR2009-014616-36-FRAgence nationale de recherches sur le sida et les hépatites virales. ANRS.
已完成
不适用
Testing strategies to improve breathlessness and related symptoms in people with lung cancerLung cancerACTRN12612000925842Queensland University of Technology18